TXN TEXAS INSTRUMENTS INC
Semiconductors & Related Devices · Nasdaq · SEC CIK 97476 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY20.3%
TTM net income YoY41.0%
TTM EPS YoY40.4%
Revenue 3-yr CAGR4.7%
Net income 3-yr CAGR0.1%
Margins
Gross margin60.2%
Operating margin40.8%
Net margin34.3%
FCF margin35.2%
EBITDA margin51.3%
Returns
ROE39.7%
ROA19.8%
ROIC (approx.)26.5%
Asset turnover0.58x
Leverage & solvency
Liabilities / assets47.9%
Debt / equity0.71x
Current ratio5.59x
Interest coverage15.01x
Cash quality & payout
Operating cash flow / net income1.39x
Accruals ratio-7.7%
Payout ratio72.7%
Capex / revenue12.4%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $17.68B | $15.64B | $17.52B | $20.03B | $18.34B |
| Cost of revenue | $7.60B | $6.55B | $6.50B | $6.26B | $5.97B |
| Gross profit | $10.08B | $9.09B | $11.02B | $13.77B | $12.38B |
| R&D expense | $2.08B | $1.96B | $1.86B | $1.67B | $1.55B |
| SG&A expense | $1.86B | $1.79B | $1.82B | $1.70B | $1.67B |
| Operating income | $6.02B | $5.46B | $7.33B | $10.14B | $8.96B |
| Interest expense | $543.00M | $508.00M | $353.00M | $214.00M | $184.00M |
| Pretax income | $5.71B | $5.45B | $7.42B | $10.03B | $8.92B |
| Income tax | $709.00M | $654.00M | $908.00M | $1.28B | $1.15B |
| Net income | $5.00B | $4.80B | $6.51B | $8.75B | $7.77B |
| EBITDA | $7.94B | $6.97B | $8.51B | $11.06B | $9.71B |
| EPS (basic) | 5.47 | 5.24 | 7.13 | 9.51 | 8.38 |
| EPS (diluted) | 5.45 | 5.20 | 7.07 | 9.41 | 8.26 |
| Dividends declared per share | 5.50 | 5.26 | 5.02 | 4.69 | 4.21 |
| Weighted avg. shares (diluted) | 913.00M | 919.00M | 916.00M | 926.00M | 936.00M |
| Balance sheet | |||||
| Cash & equivalents | $3.23B | $3.20B | $2.96B | $3.05B | $4.63B |
| Short-term investments | $1.66B | $4.38B | $5.61B | $6.02B | $5.11B |
| Receivables | $1.96B | $1.72B | $1.79B | $1.90B | $1.70B |
| Inventory | $4.80B | $4.53B | $4.00B | $2.76B | $1.91B |
| Current assets | $13.75B | $15.03B | $15.12B | $14.02B | $13.69B |
| PP&E, net | $12.32B | $11.35B | $10.00B | $6.88B | $5.14B |
| Goodwill | $4.33B | $4.36B | $4.36B | $4.36B | $4.36B |
| Intangibles | $238.00M | — | — | — | — |
| Total assets | $34.59B | $35.51B | $32.35B | $27.21B | $24.68B |
| Current liabilities | $3.16B | $3.64B | $3.32B | $2.98B | $2.57B |
| Short-term debt | $500.00M | $750.00M | $599.00M | $500.00M | $500.00M |
| Long-term debt | $13.55B | $12.85B | $10.62B | $8.23B | $7.24B |
| Total debt | $14.05B | $13.60B | $11.22B | $8.73B | $7.74B |
| Total liabilities | $18.31B | $18.61B | $15.45B | $12.63B | $11.34B |
| Shareholders' equity | $16.27B | $16.90B | $16.90B | $14.58B | $13.33B |
| Net debt | $10.82B | $10.40B | $8.26B | $5.68B | $3.11B |
| Cash flow statement | |||||
| Operating cash flow | $7.15B | $6.32B | $6.42B | $8.72B | $8.76B |
| Capital expenditure | $4.55B | $4.82B | $5.07B | $2.80B | $2.46B |
| Free cash flow | $2.60B | $1.50B | $1.35B | $5.92B | $6.29B |
| Investing cash flow | -$1.44B | -$3.20B | -$4.36B | -$3.58B | -$4.09B |
| Financing cash flow | -$5.69B | -$2.88B | -$2.14B | -$6.72B | -$3.14B |
| Depreciation & amortization | $1.92B | $1.51B | $1.18B | $925.00M | $755.00M |
| Stock-based compensation | $419.00M | $387.00M | $362.00M | $289.00M | $230.00M |
| Dividends paid | $5.00B | $4.79B | $4.56B | $4.30B | $3.89B |
| Share buybacks | $1.48B | $929.00M | $293.00M | $3.62B | $527.00M |
Free plan shows the latest 5 periods; Pro shows all 19 🔒
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.